Gray Gregory C, McCarthy Troy, Lebeck Mark G, Schnurr David P, Russell Kevin L, Kajon Adriana E, Landry Marie L, Leland Diane S, Storch Gregory A, Ginocchio Christine C, Robinson Christine C, Demmler Gail J, Saubolle Michael A, Kehl Sue C, Selvarangan Rangaraj, Miller Melissa B, Chappell James D, Zerr Danielle M, Kiska Deanna L, Halstead Diane C, Capuano Ana W, Setterquist Sharon F, Chorazy Margaret L, Dawson Jeffrey D, Erdman Dean D
Center for Emerging Infectious Diseases, Department of Epidemiology, University of Iowa College of Public Health, Iowa City, IA 52242, USA.
Clin Infect Dis. 2007 Nov 1;45(9):1120-31. doi: 10.1086/522188. Epub 2007 Sep 27.
Recently, epidemiological and clinical data have revealed important changes with regard to clinical adenovirus infection, including alterations in antigenic presentation, geographical distribution, and virulence of the virus.
In an effort to better understand the epidemiology of clinical adenovirus infection in the United States, we adopted a new molecular adenovirus typing technique to study clinical adenovirus isolates collected from 22 medical facilities over a 25-month period during 2004-2006. A hexon gene sequence typing method was used to characterize 2237 clinical adenovirus-positive specimens, comparing their sequences with those of the 51 currently recognized prototype human adenovirus strains. In a blinded comparison, this method performed well and was much faster than the classic serologic typing method.
Among civilians, the most prevalent adenovirus types were types 3 (prevalence, 34.6%), 2 (24.3%), 1 (17.7%), and 5 (5.3%). Among military trainees, the most prevalent types were types 4 (prevalence, 92.8%), 3 (2.6%), and 21 (2.4%).
For both populations, we observed a statistically significant increasing trend of adenovirus type 21 detection over time. Among adenovirus isolates recovered from specimens from civilians, 50% were associated with hospitalization, 19.6% with a chronic disease condition, 11% with a bone marrow or solid organ transplantation, 7.4% with intensive care unit stay, and 4.2% with a cancer diagnosis. Multivariable risk factor modeling for adenovirus disease severity found that age <7 years (odds ratio [OR], 3.2; 95% confidence interval [CI], 1.4-7.4), chronic disease (OR, 3.6; 95% CI, 2.6-5.1), recent transplantation (OR, 2.7; 95% CI, 1.3-5.2), and adenovirus type 5 (OR, 2.7; 95% CI, 1.5-4.7) or type 21 infection (OR, 7.6; 95% CI, 2.6-22.3) increased the risk of severe disease.
最近,流行病学和临床数据揭示了临床腺病毒感染方面的重要变化,包括病毒抗原呈现、地理分布和毒力的改变。
为了更好地了解美国临床腺病毒感染的流行病学,我们采用了一种新的分子腺病毒分型技术,对2004年至2006年25个月期间从22个医疗机构收集的临床腺病毒分离株进行研究。采用六邻体基因序列分型方法对2237份临床腺病毒阳性标本进行特征分析,将其序列与51种目前公认的原型人腺病毒株的序列进行比较。在一次盲法比较中,该方法表现良好,且比经典的血清学分型方法快得多。
在平民中,最常见的腺病毒类型是3型(流行率,34.6%)、2型(24.3%)、1型(17.7%)和5型(5.3%)。在军事受训人员中,最常见的类型是4型(流行率,92.8%)、3型(2.6%)和21型(2.4%)。
对于这两个人群,我们观察到随着时间的推移,21型腺病毒检测呈统计学上显著的上升趋势。在从平民标本中分离出的腺病毒中,50%与住院有关,19.6%与慢性病有关,11%与骨髓或实体器官移植有关,7.4%与入住重症监护病房有关,4.2%与癌症诊断有关。对腺病毒疾病严重程度进行多变量危险因素建模发现,年龄<7岁(比值比[OR],3.2;95%置信区间[CI],1.4 - 7.4)、慢性病(OR,3.6;95% CI,2.6 - 5.1)、近期移植(OR,2.7;95% CI,1.3 - 5.2)以及5型(OR,2.7;95% CI,1.5 - 4.7)或21型腺病毒感染(OR,7.6;95% CI,2.6 - 22.3)会增加严重疾病的风险。